Carregant...
Bone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myeloma
Skeletal lesions contribute substantially to morbidity and mortality in patients with cancer. The disease manifestation course during metastatic bone disease is driven by tumour cells in the bone marrow, which alter the functions of bone-resorbing (osteoclasts) and bone-forming (osteoblasts) cells,...
Guardat en:
| Publicat a: | Bonekey Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4606491/ https://ncbi.nlm.nih.gov/pubmed/26512321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bonekey.2015.113 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|